94 results
Page 2 of 5
6-K
q9utqqb 1zhsos1
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
EX-99.1
hy66iuhke3uc6euomf6
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
EX-99.1
n3f4r vie5nf3
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.2
oog01l
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.3
namofq
10 May 23
Current report (foreign)
7:27am
6-K
ea8uu18zx0t28omx9
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.1
p6dhx0h9aqrpeloyz
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
glwpfje520fd83idi
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
ehoqz5pxrrb
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
6uj nepyu9
2 Dec 22
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
5:08pm
6-K/A
EX-99.1
lcot 16ww8
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
gn35qymh
14 Nov 22
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
7:59am
6-K
EX-99.1
f2gxp2758a9vlzibed37
14 Nov 22
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
7:59am
6-K
EX-99.2
ctgdne8 tbhfe1
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
fdhd42 ah18k4xv
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
en5j2jpi b0pj2yrsn
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.3
5uq65ywg
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
lkvkr40iz0db70q2a9
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-99.1
szjf8
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
1t0yy5a479e4
9 Sep 22
Prospectus supplement for primary offering
4:23pm